Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer

Cancer Treat Rev. 2005 May;31(3):236-41. doi: 10.1016/j.ctrv.2005.03.003.

Authors

Desmond Yip¹, David Goldstein

Affiliation

¹ The Canberra Hospital, Australian National University Medical School, Canberra, Australia.

PMID: 15882933
DOI: 10.1016/j.ctrv.2005.03.003

No abstract available